Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir.
Saved in:
| Title: | Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir. |
|---|---|
| Authors: | Zamzamy M; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany., Post S; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany., Ip WH; Research Department Viral Transformation, Leibniz Institute of Virology, Hamburg, Germany., Hahlin E; Research Department of Clinical Microbiology, Umeå University, Umeå, Sweden.; Umeå Centre for Microbial Research (UCMR), Umeå University, Umeå, Sweden.; Molecular Infection Biology Sweden (MIMS), Umeå University, Umeå, Sweden.; Science for Life Laboratory (SciLifeLab), Umeå University, Umeå, Sweden., Kühn S; Technology Platform Microscopy and Image Analysis, Leibniz Institute of Virology, Hamburg, Germany., Pirosu A; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany., Conze C; Technology Platform Microscopy and Image Analysis, Leibniz Institute of Virology, Hamburg, Germany., Baumdick M; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; Division for Regenerative Medicine and Immunology, III. Department of Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Bunders MJ; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; Division for Regenerative Medicine and Immunology, III. Department of Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Zecher BF; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; I. Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Hoelzemer A; I. Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Institute for Infection Research and Vaccine Development (IIRVD), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Linder S; Institute for Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Arnberg N; Research Department of Clinical Microbiology, Umeå University, Umeå, Sweden.; Umeå Centre for Microbial Research (UCMR), Umeå University, Umeå, Sweden.; Molecular Infection Biology Sweden (MIMS), Umeå University, Umeå, Sweden.; Science for Life Laboratory (SciLifeLab), Umeå University, Umeå, Sweden., Dobner T; Research Department Viral Transformation, Leibniz Institute of Virology, Hamburg, Germany., Altfeld M; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany., Schloer S; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; Institute of Immunology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. |
| Source: | British journal of pharmacology [Br J Pharmacol] 2026 Apr; Vol. 183 (7), pp. 1578-1601. Date of Electronic Publication: 2025 Nov 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
